Integrating subvolume dose and myocardial perfusion imaging parameters to assess the impact of radiation therapy on heart function in breast cancer patients: A comparative analysis between left- and right-sided breast cancer.


Journal

Thoracic cancer
ISSN: 1759-7714
Titre abrégé: Thorac Cancer
Pays: Singapore
ID NLM: 101531441

Informations de publication

Date de publication:
09 2023
Historique:
revised: 14 07 2023
received: 14 04 2023
accepted: 17 07 2023
medline: 12 9 2023
pubmed: 9 8 2023
entrez: 9 8 2023
Statut: ppublish

Résumé

This study aimed to utilize an innovative method of integrating the 20 subvolume dose of left ventricle and the Tl-201 single photon emission computed tomography (SPECT) with myocardial perfusion imaging (MPI) parameters in patients with left- and right-sided breast cancer after radiation therapy. Female patients with breast cancer underwent SPECT MPI before commencing radiotherapy and 12 months later were enrolled from January 2014 to December 2018. The images of CT simulation and SPECT MPI were integrated into the treatment planning system. The differences of doses and parameters of MPI in all cardiac subvolumes between left- and right-sided breast cancer patients were analyzed. Patients with left-sided breast cancer (n = 61) received a higher radiation dose to the heart, left ventricular, and its territories and subvolumes, compared to patients with right-sided breast cancer (n = 19). The 20-segment analysis also showed statistically significant disparities in the average radiation doses received by the two groups. In different coronary artery territories, the end-diastolic perfusion and end-systolic perfusion showed a decrease in both sides, with no significant differences. However, the wall motion and wall thickening showed a significant decline in subregions within the left- and right-sided coronary artery territories. This study demonstrates an innovative integrated method combining the left ventricular 20 regional doses with SPECT MPI which shows that left-sided breast cancer patients receive a higher subvolume dose than right-sided breast cancer patients. Further research is needed to confirm the potential impact on heart function after radiotherapy on both sides.

Sections du résumé

BACKGROUND
This study aimed to utilize an innovative method of integrating the 20 subvolume dose of left ventricle and the Tl-201 single photon emission computed tomography (SPECT) with myocardial perfusion imaging (MPI) parameters in patients with left- and right-sided breast cancer after radiation therapy.
METHODS
Female patients with breast cancer underwent SPECT MPI before commencing radiotherapy and 12 months later were enrolled from January 2014 to December 2018. The images of CT simulation and SPECT MPI were integrated into the treatment planning system. The differences of doses and parameters of MPI in all cardiac subvolumes between left- and right-sided breast cancer patients were analyzed.
RESULTS
Patients with left-sided breast cancer (n = 61) received a higher radiation dose to the heart, left ventricular, and its territories and subvolumes, compared to patients with right-sided breast cancer (n = 19). The 20-segment analysis also showed statistically significant disparities in the average radiation doses received by the two groups. In different coronary artery territories, the end-diastolic perfusion and end-systolic perfusion showed a decrease in both sides, with no significant differences. However, the wall motion and wall thickening showed a significant decline in subregions within the left- and right-sided coronary artery territories.
CONCLUSION
This study demonstrates an innovative integrated method combining the left ventricular 20 regional doses with SPECT MPI which shows that left-sided breast cancer patients receive a higher subvolume dose than right-sided breast cancer patients. Further research is needed to confirm the potential impact on heart function after radiotherapy on both sides.

Identifiants

pubmed: 37553772
doi: 10.1111/1759-7714.15056
pmc: PMC10493477
doi:

Substances chimiques

Thallium-201 H91Z8HBK1B
Thallium Radioisotopes 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2696-2706

Informations de copyright

© 2023 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.

Références

Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):182-190
pubmed: 28816145
Lancet. 2011 Nov 12;378(9804):1707-16
pubmed: 22019144
Radiat Oncol. 2019 Feb 7;14(1):29
pubmed: 30732640
Pract Radiat Oncol. 2015 Nov-Dec;5(6):358-65
pubmed: 26231594
Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):268-76
pubmed: 25968824
Radiother Oncol. 2002 Jul;64(1):53-63
pubmed: 12208576
J Nucl Med. 2002 Apr;43(4):443-50
pubmed: 11937586
J Natl Cancer Inst. 2005 Jan 19;97(2):116-26
pubmed: 15657341
Radiother Oncol. 2019 Mar;132:257-265
pubmed: 30446318
Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):959-64
pubmed: 23021709
J Clin Oncol. 2017 Apr 10;35(11):1171-1178
pubmed: 28095159
Radiother Oncol. 2009 Jan;90(1):127-35
pubmed: 19008005
Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1125-34
pubmed: 17145533
N Engl J Med. 2013 Mar 14;368(11):987-98
pubmed: 23484825
Int J Radiat Oncol Biol Phys. 2003 Mar 15;55(4):914-20
pubmed: 12605969
Radiat Oncol. 2019 Nov 14;14(1):204
pubmed: 31727075
JACC CardioOncol. 2021 Sep 21;3(3):381-392
pubmed: 34604798
Radiat Oncol. 2015 Sep 22;10:200
pubmed: 26391237
Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):214-23
pubmed: 16111592
Int J Radiat Oncol Biol Phys. 2015 Nov 15;93(4):845-53
pubmed: 26530753
Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1149-1158
pubmed: 30012527
Radiat Oncol. 2021 May 13;16(1):89
pubmed: 33985547
Radiother Oncol. 2015 May;115(2):171-8
pubmed: 26072421
Int J Cardiovasc Imaging. 2017 Apr;33(4):463-472
pubmed: 27873127
Lancet. 2005 Dec 17;366(9503):2087-106
pubmed: 16360786
Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1116-1123
pubmed: 28721895
Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):392-400
pubmed: 30763659
Cardiol Res Pract. 2011 Feb 27;2011:317659
pubmed: 21403872
Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):1023-8
pubmed: 11240243
J Nucl Cardiol. 2018 Jun;25(3):754-757
pubmed: 29476455
J Nucl Cardiol. 2020 Feb;27(1):241-250
pubmed: 30171522
Cancer. 2007 Oct 15;110(8):1840-50
pubmed: 17763369
Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1444-51
pubmed: 20605341
Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):182-90
pubmed: 24725701
Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1172-8
pubmed: 23149005
J Nucl Cardiol. 2021 Dec;28(6):2545-2556
pubmed: 32060856
Thorac Cancer. 2023 Sep;14(26):2696-2706
pubmed: 37553772
Bioengineering (Basel). 2022 May 16;9(5):
pubmed: 35621491

Auteurs

Shan-Ying Wang (SY)

Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Department of Nuclear Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.

Wei-Ta Tsai (WT)

Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Department of Radiation Oncology, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan.

Kuan-Heng Lin (KH)

Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Division of Radiation Oncology, Department of Radiology, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
Industrial Ph.D. Program of Biomedical Science and Engineering, National Yang Ming Chiao Tung University, Taipei, Taiwan.

Chih-Wei Yu (CW)

Department of Radiation Oncology, China Medical University Hsinchu Hospital, Zhubei City, Taiwan.
Institute of Nuclear Engineering and Science, National Tsing Hua University, Hsinchu City, Taiwan.

Shu-Ya Yang (SY)

Department of Nuclear Medicine, Cheng Hsin General Hospital, Taipei, Taiwan.

Pei-Wei Shueng (PW)

Division of Radiation Oncology, Department of Radiology, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.

Yen-Wen Wu (YW)

Department of Nuclear Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Division of Cardiology, Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City, Taiwan.

Chen-Xiong Hsu (CX)

Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Division of Radiation Oncology, Department of Radiology, Far Eastern Memorial Hospital, New Taipei City, Taiwan.

Tung-Hsin Wu (TH)

Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH